Metabolites· 2026Q2
Quercetin Attenuates Metabolic Dysfunction and Reshapes Hypothalamic m6A-Related, Leptin–Insulin, and Melanocortin-Associated Transcription in High-Fat-Diet-Fed Rats
- 0citations
- Q2SCImago
- 2026year
Short summary
Quercetin administration (100 mg/kg/day) to rats fed a high-fat diet (HFD) for 16 weeks significantly reduced glucose area under the curve (AUC) by 2415 mg·min/dL (q=0.0029), visceral fat by 5.16 g (q=0.004), and triglycerides by 47.03 mg/dL (q<0.001) compared to HFD alone, without affecting final body weight.
AI-generated from the title and abstract; the full text is not read.
Key points
- Quercetin (100 mg/kg/day) significantly reduced glucose AUC by 2415 mg·min/dL (q=0.0029) in HFD-fed rats.
- Visceral fat mass was reduced by 5.16 g (q=0.004) and triglycerides by 47.03 mg/dL (q<0.001) with quercetin treatment under HFD conditions.
- Quercetin's metabolic benefits in HFD rats were observed without a significant change in final body weight.
- Diet and quercetin interactions were significant for 15 out of 21 hypothalamic transcripts analyzed, indicating quercetin reshapes gene expression in response to HFD.
AI-generated from the title and abstract; the full text is not read.
Abstract
Background/Objectives: High-fat diet (HFD) feeding disrupts systemic metabolism and hypothalamic mechanisms that coordinate energy balance. Whether quercetin modifies coordinated hypothalamic transcription linking m6A-related regulation with leptin–insulin- and melanocortin-associated biology remains unclear. We examined the metabolic and hypothalamic transcriptional response to quercetin during chronic HFD exposure. Methods: Male Wistar rats were studied for 16 weeks in a 2 × 2 factorial design: Control (n = 8), Control + quercetin (n = 5), HFD (n = 5), and HFD + quercetin (n = 6). Quercetin was administered orally at 100 mg/kg/day. Body weight, fasting glucose, food/fluid intake, calculated energy intake, oral glucose tolerance, terminal adiposity, lipids, and a 21-transcript hypothalamic RT-qPCR panel were evaluated. Analyses included factorial models with HC3 inference and FDR control, PCA/PERMANOVA, predefined transcriptional modules, bootstrap and leave-one-sample-out sensitivity analyses, treatment-adjusted covariance, and shrinkage regularization. Results: At week 16, HFD + quercetin reduced glucose AUC relative to HFD by 2415 mg·min/dL (q = 0.0029), visceral fat by 5.16 g (q = 0.004), and triglycerides by 47.03 mg/dL (q < 0.001), without a corresponding difference in final body weight. Diet × quercetin interactions were supported for week-16 AUC, visceral adiposity, triglycerides, and 15 of 21 hypothalamic transcripts. Sixteen of 21 transcripts met robustness criteria for the HFD + quercetin versus HFD contrast. PC1 and PC2 captured 73.5% of transcriptional variance, and all three predefined transcriptional modules showed robust diet-dependent responses. Regularized covariance sensitivity preserved the direction of all 210 treatment-adjusted transcript associations. Conclusions: The principal metabolic effects of quercetin were predominantly evident under HFD conditions and were accompanied by coordinated hypothalamic transcriptional remodeling across m6A-related, leptin–insulin-associated, and melanocortin-associated domains. These data define a transcriptional architecture for mechanistic follow-up without implying direct measurement of circulating leptin or insulin, m6A activity, protein abundance, or pathway activation.
The authors' abstract, as published at the source. Metabolites, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Endocrine and Autonomic Systems
Endocrine and Autonomic SystemsNeuroscience